The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
Open accessAbstract
Interleukin 17 (IL-17) is a proinflammatory cytokine that has been the focus of intensive research because of its crucial role in the pathogenesis of different diseases across many medical specialties. In this context, the present review in which a panel of 13 experts in immunology, dermatology, rheumatology, neurology, hematology, infectious diseases, hepatology, cardiology, ophthalmology and oncology have been involved, puts in common the mechanisms through which IL-17 is considered a molecular target for the development of novel biological therapies in these different fields. A comprehensive review of the literature and analysis of the most outstanding evidence have provided the basis for discussing the most relevant data related to IL-17A blocking agents for the treatment of different disorders, such as psoriasis, psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, cardiovascular disorders, non alcoholic fatty liver disease, multiple sclerosis, inflammatory bowel disease, uveitis, hematological and solid cancer. Current controversies are presented giving an opening line for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,786
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492
Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.039 · Cited by 1,819
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
Structure and signalling in the IL-17 receptor family
Gaffen, S. L. (2009) · Nature reviews. Immunology · doi:10.1038/nri2586 · Cited by 1,475
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y., Younossi, Y., Mir, H., & Srishord, M. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,073
IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4−CD8− entheseal resident T cells
Sherlock, J. P., Joyce-Shaikh, B., Turner, S. P., Chao, C.-C., Sathe, M., Grein, J., Gorman, D. M., Bowman, E. P., McClanahan, T. K., Yearley, J. H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2817 · Cited by 1,060
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30475-6 · Cited by 942
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
Amadi-Obi, A., Yu, C.-R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt, R. B., Gery, I., Lee, Y. S., & Egwuagu, C. E. (2007) · Nature Medicine · doi:10.1038/nm1585 · Cited by 865
Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B., Blauvelt, A., Papp, K. A., Langley, R. G., Luger, T., Ohtsuki, M., Reich, K., Amato, D., Ball, S. G., Braun, D. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512711 · Cited by 848
Interleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
Madhur, M. S., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J., & Harrison, D. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145094 · Cited by 827
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
Brunner, P. M., Guttman-Yassky, E., & Leung, D. Y. M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.011 · Cited by 642
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
Patel, D. D., & Kuchroo, V. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.12.003 · Cited by 486
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa
Schlapbach, C., Hänni, T., Yawalkar, N., & Hunger, R. E. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.07.010 · Cited by 425
Hasegawa, T., Yoneda, M., Nakamura, K., Makino, I., & Terano, A. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01083.x · Cited by 408
IL-17 in Chronic Inflammation: From Discovery to Targeting
Beringer, A., Noack, M., & Miossec, P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.001 · Cited by 402
Gomes, A. L., Teijeiro, A., Burén, S., Tummala, K. S., Yilmaz, M., Waisman, A., Theurillat, J.-P., Perna, C., & Djouder, N. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.020 · Cited by 401
The interleukin-17 pathway is involved in human alcoholic liver disease # †
Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., de Nadai, P., Geerts, A., Quertinmont, E., Vercruysse, V., et al. (2009) · Hepatology · doi:10.1002/hep.22680 · Cited by 394
Baeten, D., Østergaard, M., Wei, J. C.-C., Sieper, J., Järvinen, P., Tam, L.-S., Salvarani, C., Kim, T.-H., Solinger, A., Datsenko, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-213328 · Cited by 390
Targan, S. R., Feagan, B., Vermeire, S., Panaccione, R., Melmed, G. Y., Landers, C., Li, D., Russell, C., Newmark, R., Zhang, N., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.298 · Cited by 383
Jandus, C., Bioley, G., Rivals, J., Dudler, J., Speiser, D., & Romero, P. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23655 · Cited by 382
Molecular pathways in non-alcoholic fatty liver disease
Auguet, T., Berlanga, A., Guiu-Jurado, E., & Porras, J. A. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s62831 · Cited by 379
T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β
Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B., Eid, P., & Novelli, F. (2009) · Annals of Neurology · doi:10.1002/ana.21652 · Cited by 375
How we treat chronic graft-versus-host disease
Flowers, M. E. D., & Martin, P. J. (2015) · Blood · doi:10.1182/blood-2014-08-551994 · Cited by 371
Dick, A. D., Tugal-Tutkun, I., Foster, S., Zierhut, M., Melissa Liew, S. H., Bezlyak, V., & Androudi, S. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.040 · Cited by 365
Liu, J., Duan, Y., Cheng, X., Chen, X., Xie, W., Long, H., Lin, Z., & Zhu, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.021 · Cited by 361
Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342
The role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
Dual nature of the adaptive immune system in lampreys
Guo, P., Hirano, M., Herrin, B. R., Li, J., Yu, C., Sadlonova, A., & Cooper, M. D. (2009) · Nature · doi:10.1038/nature08068 · Cited by 336
Th17 Cells in Cancer: The Ultimate Identity Crisis
Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00276 · Cited by 334
He, D., Li, H., Yusuf, N., Elmets, C. A., Li, J., Mountz, J. D., & Xu, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902574 · Cited by 334
Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
Asrih, M., & Jornayvaz, F. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.018 · Cited by 330
Barchetta, I., Angelico, F., Ben, M. D., Baroni, M. G., Pozzilli, P., Morini, S., & Cavallo, M. G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-85 · Cited by 323
Upregulated IL-23 and IL-17 in Behçet Patients with Active Uveitis
Chi, W., Zhu, X., Yang, P., Liu, X., Lin, X., Zhou, H., Huang, X., & Kijlstra, A. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1390 · Cited by 321
Blauvelt, A., Reich, K., Tsai, T.-F., Tyring, S., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Vender, R., Hugot, S., et al. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.008 · Cited by 312
Differentiation, phenotype, and function of interleukin-17–producing human Vγ9Vδ2 T cells
Caccamo, N., La Mendola, C., Orlando, V., Meraviglia, S., Todaro, M., Stassi, G., Sireci, G., Fournié, J. J., & Dieli, F. (2011) · Blood · doi:10.1182/blood-2011-01-331298 · Cited by 307
Carlson, M. J., West, M. L., Coghill, J. M., Panoskaltsis-Mortari, A., Blazar, B. R., & Serody, J. S. (2009) · Blood · doi:10.1182/blood-2008-06-162420 · Cited by 302
Jenq, R. R., & van den Brink, M. R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2804 · Cited by 299
Liao, Y.-H., Xia, N., Zhou, S.-F., Tang, T.-T., Yan, X.-X., Lv, B.-J., Nie, S.-F., Wang, J., Iwakura, Y., Xiao, H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.10.863 · Cited by 295
Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
Tang, Y., Bian, Z., Zhao, L., Liu, Y., Liang, S., Wang, Q., Han, X., Peng, Y., Chen, X., Shen, L., et al. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04471.x · Cited by 294
Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293 · cited 1×
“and Staphylococcus aureus [13], unrestrained IL-17 production has been demonstrated to be involved in”
BackgroundMenon, B., Gullick, N. J., Walter, G. J., Rajasekhar, M., Garrood, T., Evans, H. G., Taams, L. S., & Kirkham, B. W. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38376 · Cited by 293
Clinically resolved psoriatic lesions contain psoriasis-specific IL-17–producing αβ T cell clones
Matos, T. R., O’Malley, J. T., Lowry, E. L., Hamm, D., Kirsch, I. R., Robins, H. S., Kupper, T. S., Krueger, J. G., & Clark, R. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93396 · Cited by 285
IL-27 Is a Key Regulator of IL-10 and IL-17 Production by Human CD4+ T Cells
Murugaiyan, G., Mittal, A., Lopez-Diego, R., Maier, L. M., Anderson, D. E., & Weiner, H. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900568 · Cited by 276
Braun, J., Baraliakos, X., Deodhar, A., Baeten, D., Sieper, J., Emery, P., Readie, A., Martin, R., Mpofu, S., & Richards, H. B. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209730 · Cited by 273
Interleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis
Noordenbos, T., Yeremenko, N., Gofita, I., van de Sande, M., Tak, P. P., Caňete, J. D., & Baeten, D. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33396 · Cited by 270
Self-citationWeiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256
Inflammatory T helper 17 cells promote depression-like behavior in mice
Beurel, E., Harrington, L. E., & Jope, R. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.021 · Cited by 254
Nam, J.-S., Terabe, M., Kang, M.-J., Chae, H., Voong, N., Yang, Y.-A., Laurence, A., Michalowska, A., Mamura, M., Lonning, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0206 · Cited by 251
Zhu, X., Mulcahy, L. A., Mohammed, R. A., Lee, A. H., Franks, H. A., Kilpatrick, L., Yilmazer, A., Paish, E. C., Ellis, I. O., Patel, P. M., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2195 · Cited by 250
Elnabawi, Y. A., Dey, A. K., Goyal, A., Groenendyk, J. W., Chung, J. H., Belur, A. D., Rodante, J., Harrington, C. L., Teague, H. L., Baumer, Y., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz009 · Cited by 248
Kirkham, B. W., Kavanaugh, A., & Reich, K. (2014) · Immunology · doi:10.1111/imm.12142 · Cited by 243
Gerber, L., Otgonsuren, M., Mishra, A., Escheik, C., Birerdinc, A., Stepanova, M., & Younossi, Z. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12038 · Cited by 234
Li, J., Lau, G. K.-K., Chen, L., Dong, S.-S., Lan, H.-Y., Huang, X.-R., Li, Y., Luk, J. M., Yuan, Y.-F., & Guan, X.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021816 · Cited by 232
Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity
Burkett, P. R., Meyer zu Horste, G., & Kuchroo, V. K. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78085 · Cited by 226
Arai, S., Jagasia, M., Storer, B., Chai, X., Pidala, J., Cutler, C., Arora, M., Weisdorf, D. J., Flowers, M. E. D., Martin, P. J., et al. (2011) · Blood · doi:10.1182/blood-2011-03-344390 · Cited by 224
Havrdová, E., Belova, A., Goloborodko, A., Tisserant, A., Wright, A., Wallstroem, E., Garren, H., Maguire, R. P., & Johns, D. R. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8128-x · Cited by 224
von Stebut, E., Reich, K., Thaçi, D., Koenig, W., Pinter, A., Körber, A., Rassaf, T., Waisman, A., Mani, V., Yates, D., et al. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.10.042 · Cited by 224
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Chen, X., Wan, J., Liu, J., Xie, W., Diao, X., Xu, J., Zhu, B., & Chen, Z. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.013 · Cited by 217
Zhang, L., Li, Y.-G., Li, Y.-H., Qi, L., Liu, X.-G., Yuan, C.-Z., Hu, N.-W., Ma, D.-X., Li, Z.-F., Yang, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031000 · Cited by 216
Bissonnette, R., Luger, T., Thaçi, D., Toth, D., Lacombe, A., Xia, S., Mazur, R., Patekar, M., Charef, P., Milutinovic, M., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14878 · Cited by 200
The translational revolution and use of biologics in patients with inflammatory skin diseases
Noda, S., Krueger, J. G., & Guttman-Yassky, E. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.015 · Cited by 198
IL-23/IL-17 immunity as a hallmark of Crohnʼs disease
Hölttä, V., Klemetti, P., Sipponen, T., Westerholm-Ormio, M., Kociubinski, G., Salo, H., Räsänen, L., Kolho, K.-L., Färkkilä, M., Savilahti, E., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20475 · Cited by 196
Xiang, T., Long, H., He, L., Han, X., Lin, K., Liang, Z., Zhuo, W., Xie, R., & Zhu, B. (2015) · Oncogene · doi:10.1038/onc.2013.537 · Cited by 194
Blanco, F. J., Möricke, R., Dokoupilova, E., Codding, C., Neal, J., Andersson, M., Rohrer, S., & Richards, H. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40070 · Cited by 185
IL-17 in obesity and adipogenesis
Ahmed, M., & Gaffen, S. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.005 · Cited by 185
Matusiak, Ł., Szczęch, J., Bieniek, A., Nowicka-Suszko, D., & Szepietowski, J. C. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.10.042 · Cited by 185
Simon, T., Taleb, S., Danchin, N., Laurans, L., Rousseau, B., Cattan, S., Montely, J.-M., Dubourg, O., Tedgui, A., Kotti, S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs263 · Cited by 184
Jiang, W., Su, J., Zhang, X., Cheng, X., Zhou, J., Shi, R., & Zhang, H. (2014) · Inflammation Research · doi:10.1007/s00011-014-0768-7 · Cited by 181
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study
Feagan, B. G., Panés, J., Ferrante, M., Kaser, A., D’Haens, G., Sandborn, W. J., Louis, E. J., Neurath, M. F., Franchimont, D. P., Dewit, O., et al. (2018) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(18)30233-4 · Cited by 180
IL-17A as an Inducer for Th2 Immune Responses in Murine Atopic Dermatitis Models
Nakajima, S., Kitoh, A., Egawa, G., Natsuaki, Y., Nakamizo, S., Moniaga, C. S., Otsuka, A., Honda, T., Hanakawa, S., Amano, W., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.51 · Cited by 169
Chronic mucocutaneous candidiasis disease associated with inborn errors of IL‐17 immunity
Okada, S., Puel, A., Casanova, J., & Kobayashi, M. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.71 · Cited by 167
Letko, E., Yeh, S., Foster, C. S., Pleyer, U., Brigell, M., & Grosskreutz, C. L. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.12.033 · Cited by 166
Rolla, S., Alchera, E., Imarisio, C., Bardina, V., Valente, G., Cappello, P., Mombello, C., Follenzi, A., Novelli, F., & Carini, R. (2016) · Clinical Science · doi:10.1042/cs20150405 · Cited by 158
Hu, D., Notarbartolo, S., Croonenborghs, T., Patel, B., Cialic, R., Yang, T.-H., Aschenbrenner, D., Andersson, K., Gattorno, M., Pham, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01571-8 · Cited by 156
Expression of IL-17 mRNA in Ovarian Cancer
Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M., & Aono, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4618 · Cited by 152
Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis
Qian, X., Chen, H., Wu, X., Hu, L., Huang, Q., & Jin, Y. (2016) · Cytokine · doi:10.1016/j.cyto.2015.09.011 · Cited by 152
Effects of Interleukin 17 on the cardiovascular system
Robert, M., & Miossec, P. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.009 · Cited by 147
Targeting CD8+ T cells prevents psoriasis development
Meglio, P. D., Villanova, F., Navarini, A. A., Mylonas, A., Tosi, I., Nestle, F. O., & Conrad, C. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.046 · Cited by 145
Batista, D. I. S., Perez, L., Orfali, R. L., Zaniboni, M. C., Samorano, L. P., Pereira, N. V., Sotto, M. N., Ishizaki, A. S., Oliveira, L. M. D. S., Sato, M. N., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12753 · Cited by 144
Smolen, J. S., Agarwal, S. K., Ilivanova, E. P., Xu, X. L., Ye, M., Zhuang, Y., Nnane, I. P., Radziszewski, W., Greenspan, A. J., Beutler, A. M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209831 · Cited by 144
Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis
Belasco, J., Louie, J. S., Gulati, N., Wei, N., Nograles, K. E., Fuentes‐Duculan, J., Mitsui, H., Suárez‐Fariñas, M., & Krueger, J. G. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38995 · Cited by 130
Brüggen, M., Klein, I., Greinix, H., Bauer, W. M., Kuzmina, Z. J., Rabitsch, W., Kalhs, P., Petzelbauer, P., Knobler, R., Stingl, G., et al. (2013) · Blood · doi:10.1182/blood-2013-07-514372 · Cited by 128
Cellular sources of IL ‐17 in psoriasis: a paradigm shift?
Keijsers, R. R. M. C., Joosten, I., van Erp, P. E. J., Koenen, H. J. P. M., & van de Kerkhof, P. C. M. (2014) · Experimental Dermatology · doi:10.1111/exd.12487 · Cited by 128
Mechanisms controlling Th17 cytokine expression and host defense
McAleer, J. P., & Kolls, J. K. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0211099 · Cited by 125
Cirée, A., Michel, L., Camilleri‐Broët, S., Jean‐Louis, F., Oster, M., Flageul, B., Senet, P., Fossiez, F., Fridman, W. H., Bachelez, H., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20373 · Cited by 124
Are psoriasis and psoriatic arthritis the same disease? The IL-23/IL-17 axis data
Sakkas, L. I., & Bogdanos, D. P. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.015 · Cited by 124
Kahraman, A., Schlattjan, M., Kocabayoglu, P., Yildiz-Meziletoglu, S., Schlensak, M., Fingas, C. D., Wedemeyer, I., Marquitan, G., Gieseler, R. K. H., Baba, H. A., et al. (2009) · Hepatology · doi:10.1002/hep.23253 · Cited by 123
Gartlan, K. H., Markey, K. A., Varelias, A., Bunting, M. D., Koyama, M., Kuns, R. D., Raffelt, N. C., Olver, S. D., Lineburg, K. E., Cheong, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-622662 · Cited by 122
Hirahara, N., Nio, Y., Sasaki, S., Minari, Y., Takamura, M., Iguchi, C., Dong, M., Yamasawa, K., & Tamura, K. (2001) · Oncology · doi:10.1159/000055357 · Cited by 122
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Wenfeng, Z., Wu, Y., Di, M., Jianping, G., Wu, C., & Huang, C. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31247-5 · Cited by 118
Krueger, J. G., & Brunner, P. M. (2017) · Experimental Dermatology · doi:10.1111/exd.13467 · Cited by 118
Zhu, F., Wang, Q., Guo, C., Wang, X., Cao, X., Shi, Y., Gao, F., Ma, C., & Zhang, L. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.07.003 · Cited by 114
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression
Giles, D. A., Moreno‐Fernandez, M. E., & Divanovic, S. (2015) · Current Drug Targets · doi:10.2174/1389450116666150531153627 · Cited by 108
IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases
Beringer, A., & Miossec, P. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.06.008 · Cited by 108
van Tok, M. N., van Duivenvoorde, L. M., Krämer, I., Ingold, P., Pfister, S., Roth, L., Blijdorp, I. C. J., van de Sande, M. G. H., Taurog, J. D., Kolbinger, F., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40770 · Cited by 108
Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action
Behrangi, N., Fischbach, F., & Kipp, M. (2019) · Cells · doi:10.3390/cells8010024 · Cited by 105
Subclinical gut inflammation in ankylosing spondylitis
Ciccia, F., Rizzo, A. G., & Triolo, G. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000239 · Cited by 101
Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease
Liu, R., Gao, C., Chen, H., Li, Y., Jin, Y., & Qi, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173301 · Cited by 100
Nagata, T., McKinley, L., Peschon, J. J., Alcorn, J. F., Aujla, S. J., & Kolls, J. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7473 · Cited by 99
Fábrega, E., López‐Hoyos, M., Segundo, D. S., Casafont, F., & Pons‐Romero, F. (2009) · Liver Transplantation · doi:10.1002/lt.21724 · Cited by 99
Mediators of inflammation and bone remodeling in rheumatic disease
Shaw, A. T., & Gravallese, E. M. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.10.013 · Cited by 98
IL-17A promotes ventricular remodeling after myocardial infarction
Zhou, S.-F., Yuan, J., Liao, M.-Y., Xia, N., Tang, T., Li, J.-J., Jiao, J., Dong, W.-Y., Nie, S.-F., Zhu, Z.-F., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1176-8 · Cited by 98
Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease
MacDonald, J. K., Nguyen, T. M., Khanna, R., & Timmer, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007572.pub3 · Cited by 96
Du, W., Zhen, J., Zeng, Z.-Q., Zheng, Z., Xu, Y., Qin, L.-Y., & Chen, S. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-40 · Cited by 96
van Tok, M. N., Na, S., Lao, C. R., Alvi, M., Pots, D., van de Sande, M. G. H., Taurog, J. D., Sedgwick, J. D., Baeten, D., & van Duivenvoorde, L. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01550 · Cited by 95
Yeremenko, N. G., Paramarta, J. E., & Baeten, D. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000069 · Cited by 94
Targeting the IL-17–TH17 pathway
Bartlett, H. S., & Million, R. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4518 · Cited by 94
Secukinumab failure in Crohn's disease: the yeast connection?
Colombel, J., Sendid, B., Jouault, T., & Poulain, D. (2012) · Gut · doi:10.1136/gutjnl-2012-304154 · Cited by 93
IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis
Adamopoulos, I. E., Suzuki, É., Chao, C., Gorman, D., Adda, S., Maverakis, E., Zarbalis, K. S., Geissler, R. H., Asio, A., Blumenschein, W. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204782 · Cited by 93
Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown
Liuzzo, G., Trotta, F., & Pedicino, D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs399 · Cited by 91
Cutting Edge: Homeostasis of Innate Lymphoid Cells Is Imbalanced in Psoriatic Arthritis
Soare, A., Weber, S., Maul, L., Rauber, S., Gheorghiu, A. M., Luber, M., Houssni, I., Kleyer, A., von Pickardt, G., Gado, M., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700596 · Cited by 89
Human mast cells capture, store, and release bioactive, exogenous IL-17A
Noordenbos, T., Blijdorp, I. C. J., Chen, S., Stap, J., Mul, E. P. J., Cañete, J. D. D., Lubberts, E., Yeremenko, N. G., & Baeten, D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3hi1215-542r · Cited by 87
Self-citationKavanaugh, A., Mease, P. J., Reimold, A. M., Tahir, H., Rech, J., Hall, S., Geusens, P., Wang, Z., Pricop, L., Mpofu, S., et al. (2016) · Arthritis Care & Research · doi:10.1002/acr.23111 · Cited by 87
Critical role of interleukin‐17/interleukin‐17 receptor axis in mediating Con A‐induced hepatitis
Yan, S., Wang, L., Liu, N., Wang, Y., & Chu, Y. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.59 · Cited by 81
Kampylafka, E. I., d’Oliveira, I., Linz, C., Lerchen, V., Stemmler, F., Simón, D., Englbrecht, M., Sticherling, M., Rech, J., Kleyer, A., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1653-5 · Cited by 81
Non-alcoholic fatty liver disease and psoriasis: So far, so near
Ganzetti, G., Campanati, A., & Offidani, A. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.315 · Cited by 79
The Role of IL-15 in Activating STAT5 and Fine-Tuning IL-17A Production in CD4 T Lymphocytes
Pandiyan, P., Yang, X., Saravanamuthu, S. S., Zheng, L., Ishihara, S., O’Shea, J. J., & Lenardo, M. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201476 · Cited by 77
Are cytokines and chemokines suitable biomarkers for Takayasu arteritis?
Savioli, B., Abdulahad, W. H., Brouwer, E., Kallenberg, C. G. M., & de Souza, A. W. S. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.023 · Cited by 77
Celis, R., Planell, N., FERNÁNDEZ-SUEIRO, J. L., Sanmartí, R., Ramírez, J., González‐Álvaro, I., Pablos, J. L., & Cañete, J. D. D. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3817 · Cited by 76
Self-citationAcute graft-versus-host disease is regulated by an IL-17–sensitive microbiome
Varelias, A., Ormerod, K. L., Bunting, M. D., Koyama, M., Gartlan, K. H., Kuns, R. D., Lachner, N., Locke, K. R., Lim, C. Y. H., Henden, A. S., et al. (2017) · Blood · doi:10.1182/blood-2016-08-732628 · Cited by 74
Mease, P. J., Kavanaugh, A., Reimold, A. M., Tahir, H., Rech, J., Hall, S., Geusens, P., Pellet, P., Delicha, E. M., Mpofu, S., et al. (2018) · RMD Open · doi:10.1136/rmdopen-2018-000723 · Cited by 74
Cañete, J. D. D., Celis, R., Yeremenko, N. G., Sanmartí, R., van Duivenvoorde, L. M., Ramírez, J., Blijdorp, I. C. J., García‐Herrero, C. M., Pablos, J. L., & Baeten, D. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0688-0 · Cited by 69
Self-citationLi, X.-L., Dou, Y., Liu, Y., Chang-wen, S., Cao, L., Zhang, X., Zhu, J., & Duan, R. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.08.015 · Cited by 66
Liu, X., Jin, H., Zhang, G., Lin, X., Chen, C., Sun, J., Zhang, Y., Zhang, Q., & Yu, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106834 · Cited by 64
Iversen, L., Eidsmo, L., Austad, J., de Rie, M. A., Osmančević, A., Skov, L., Talme, T., Bachmann, I., van de Kerkhof, P., Ståhle, M., et al. (2018) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14979 · Cited by 59
Egeberg, A., Thyssen, J. P., Jensen, P., Gislason, G., & Skov, L. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2657 · Cited by 58
Kang, Y., Su, G., Sun, J., & Zhang, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8586 · Cited by 54
Xu, C. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i33.4504 · Cited by 48
Shi, T., Zhang, T., Zhang, L., Yang, Y., Zhang, H., & Zhang, F. (2015) · Medicine · doi:10.1097/md.0000000000001888 · Cited by 48
Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway
Su, S., Du, Y., Zhu, W. P., Cai, Z., Zhang, N., Zhao, L., Wang, J., & Xiang, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.08.013 · Cited by 47
Interleukin-17 and type 17 helper T cells in cancer management and research
Housseau, F., Geis, A. L., Orberg, E. T., & Llosa, N. J. (2014) · ImmunoTargets and Therapy · doi:10.2147/itt.s56529 · Cited by 42
Han, R. K., Cheng, Y. F., Zhou, S., Guo, H., He, R., Jun, L., & Zhang, L. M. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9965-3 · Cited by 42
Chen, H., Ren, X., Liao, N., & Wen, F. (2016) · Journal of International Medical Research · doi:10.1177/0300060516672369 · Cited by 40
Establishing a Role for Interleukin-17 in Atopic Dermatitis-Related Skin Inflammation
Tan, Q., Yang, H., Liu, E., & Wang, H. (2017) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/1203475417697651 · Cited by 40
Therapeutic Potential of IL‐17‐Mediated Signaling Pathway in Autoimmune Liver Diseases
Zhang, H., Bernuzzi, F., Lleò, A., Ma, X., & Invernizzi, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/436450 · Cited by 38
Statins’ immunomodulatory potential against Th17 cell-mediated autoimmune response
Zhang, X., & Markovic‐Plese, S. (2008) · Immunologic Research · doi:10.1007/s12026-008-8019-z · Cited by 38
Ndongo-Thiam, N., & Miossec, P. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-207110 · Cited by 36
Effect of interleukin-17 on gene expression profile of fibroblasts from Crohn's disease patients
Kerami, Z., Duijvis, N. W., Vogels, E. W. M., van Dooren, F. H., Moerland, P. D., & Velde, A. A. T. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2014.02.009 · Cited by 34
Chaugai, S., Tan, L., Huang, J., Li, Q., Ni, L., Cianflone, K., & Wang, D. W. (2016) · Medicine · doi:10.1097/md.0000000000004105 · Cited by 34
Th17 and IL-17 immunity in chronic hepatitis C infection.
Balanescu, P. C., Lădaru, A., Voiosu, T. A., Nicolau, A., Ene, M., & Balanescu, A. (2012) · PubMed · Cited by 32
El-Ela, M. A., Gawdat, H. I., Hegazy, R. A., Fawzy, M. M., Hay, R. M. A., Saadi, D. G., & Shaker, O. G. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1617-z · Cited by 32
The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis
Heo, W. I., Lee, K. E., Hong, J. Y., Kim, M. N., Oh, M. S., Kim, Y. S., Kim, K. W., Kim, K. E., & Sohn, M. H. (2015) · Clinical and Experimental Dermatology · doi:10.1111/ced.12567 · Cited by 29
Shi, W., Zhu, Q., Gu, J., Liu, X., Lü, L., Qian, X., Shen, J., Zhang, F., & Li, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/253046 · Cited by 27
Life before seventeen: cloning of the IL-17 receptor
Gaffen, S. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102576 · Cited by 22
Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis
He, T., Huang, Y., Zhang, C., Liu, D., Cheng, C., Xu, W., & Zhang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.20823 · Cited by 21
Seventeen in Crohn's disease: less prime than we thought?
Raine, T., & Kaser, A. (2012) · Gut · doi:10.1136/gutjnl-2012-302525 · Cited by 17
Ehrenstein, M. R., & Mauri, C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071737 · Cited by 15
Neutrophils are not the dominant interleukin‐17 producer in psoriasis
Yamanaka, K., Yamagiwa, A., Akeda, T., Kondo, M., Kakeda, M., Habe, K., Imafuku, S., Sano, S., & Mizutani, H. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.13807 · Cited by 12
Specific association ofIL17Agenetic variants with panuveitis
Mucientes, A., Márquez, A., Cordero‐Coma, M., Martín‐Villa, J. M., Gorroño-Echebarría, M. B., Blanco, R., Díaz‐Valle, D., Benitez-del-Castillo, J. M., del Rio, M. J., Blanco, A., et al. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306106 · Cited by 8
Self-citation
Cited by
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Schinocca, C., Rizzo, C., Fasano, S., Grasso, G., La Barbera, L., Ciccia, F., & Guggino, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637829 · Cited by 360
Interleukin-17 in chronic inflammatory neurological diseases
Milovanovic, J., Arsenijevic, A., Stojanovic, B., Kanjevac, T., Arsenijevic, D., Radosavljevic, G., Milovanovic, M., & Arsenijevic, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00947 · Cited by 250
Tissue-resident and innate-like T cells in patients with advanced chronic liver disease
Ibidapo-Obe, O., & Bruns, T. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100812 · Cited by 25
Targeting interleukin-17 as a novel treatment option for fibrotic diseases
Sisto, M., & Lisi, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010164 · Cited by 22
Metadata
- Authors
- Ruiz de Morales, J. M. G., Puig, L., Daudén, E., Cañete, J. D., Pablos, J. L., Martín, A. O., Juanatey, C. G., Adán, A., Montalbán, X., Borruel, N., Ortí, G., Holgado-Martín, E., García-Vidal, C., Vizcaya-Morales, C., Martín-Vázquez, V., & González-Gay, M. Á.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 19
- Issue
- 1
- Pages
- 102429
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2984486845
- Cited by
- 338
- References
- 163
- FWCI
- 10.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.